Quest Diagnostics Profit Margin 2010-2024 | DGX

Current and historical gross margin, operating margin and net profit margin for Quest Diagnostics (DGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quest Diagnostics net profit margin as of March 31, 2024 is 9.11%.
Quest Diagnostics Annual Profit Margins
Quest Diagnostics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.220B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.341B 0.00
DaVita (DVA) United States $12.098B 15.03
Encompass Health (EHC) United States $8.595B 22.00
Chemed (CHE) United States $8.221B 25.48
Elanco Animal Health (ELAN) United States $6.286B 16.31
Option Care Health (OPCH) United States $5.272B 19.95
RadNet (RDNT) United States $4.581B 95.39
Amedisys (AMED) United States $3.189B 22.59
Astrana Health (ASTH) United States $2.762B 37.37
Addus HomeCare (ADUS) United States $2.150B 27.83
LifeStance Health (LFST) United States $2.103B 0.00
U.S Physical Therapy (USPH) United States $1.423B 38.08
Pennant (PNTG) United States $0.815B 43.08
Aveanna Healthcare Holdings (AVAH) United States $0.662B 0.00
Atai Life Sciences (ATAI) Germany $0.248B 0.00
Daxor (DXR) United States $0.046B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00